Abstract:The therapeutic promise of induced pluripotent stem cells (iPSCs) has spurred efforts to circumvent genome alteration when reprogramming somatic cells to pluripotency. Approaches based on episomal DNA, Sendai virus, and messenger RNA (mRNA) can generate “footprint-free” iPSCs with efficiencies equaling or surpassing those attained with integrating viral vectors. The mRNA method uniquely affords unprecedented control over reprogramming factor (RF) expression while obviating a cleanup phase to purge residual tra… Show more
“…There is always a risk of tumourigenicity associated with the use of stem cells and in particular the use of viral vectors. Newer methods that generate iPSCs without viral vectors have been developed to reduce the risk of tumourigenicity [61][62][63][64]. Overall chondrogenic differentiation of iPSCs is still in its formative stages of development and further work is required to evaluate its full potential in the field of osteochondral regeneration.…”
The treatment of cartilage defects poses a clinical challenge owing to the lack of intrinsic regenerative capacity of cartilage. The use of tissue engineering techniques to bioengineer articular cartilage is promising and may hold the key to the successful regeneration of cartilage tissue. Natural and synthetic biomaterials have been used to recreate the microarchitecture of articular cartilage through multilayered biomimetic scaffolds. Acellular scaffolds preserve the microarchitecture of articular cartilage through a process of decellularization of biological tissue. Although promising, this technique often results in poor biomechanical strength of the graft. However, biomechanical strength could be improved if biomaterials could be incorporated back into the decellularized tissue to overcome this limitation.
“…There is always a risk of tumourigenicity associated with the use of stem cells and in particular the use of viral vectors. Newer methods that generate iPSCs without viral vectors have been developed to reduce the risk of tumourigenicity [61][62][63][64]. Overall chondrogenic differentiation of iPSCs is still in its formative stages of development and further work is required to evaluate its full potential in the field of osteochondral regeneration.…”
The treatment of cartilage defects poses a clinical challenge owing to the lack of intrinsic regenerative capacity of cartilage. The use of tissue engineering techniques to bioengineer articular cartilage is promising and may hold the key to the successful regeneration of cartilage tissue. Natural and synthetic biomaterials have been used to recreate the microarchitecture of articular cartilage through multilayered biomimetic scaffolds. Acellular scaffolds preserve the microarchitecture of articular cartilage through a process of decellularization of biological tissue. Although promising, this technique often results in poor biomechanical strength of the graft. However, biomechanical strength could be improved if biomaterials could be incorporated back into the decellularized tissue to overcome this limitation.
“…37 However, limitations of such approach include inherent complexities related to cellular procedures and purification of reprogrammed cells. 37 In addition, the expression of reprogramming factors is robust for approximately 24 hours after mRNA transfection. Unfortunately, there is a long two-to three-week lag between expression of reprogramming factor proteins and induction of pluripotency in human cells.…”
Section: Challenges In Gene Delivery and Mirna Solutionsmentioning
confidence: 99%
“…Finally, repeated transfections that are needed to generate induced pluripotent stem cells is time intensive. 37 In this theme issue, we have reviewed the emergent significance of miRNA in tissue repair and regeneration. 38 The observation that miRNA does not integrate into the genome makes miRNA-based therapeutic strategies translationally valuable.…”
Section: Challenges In Gene Delivery and Mirna Solutionsmentioning
“…Therefore, iPSCs must be screened to select free cells for further applications (Gonzalez et al, 2009). To date, the safest technique of iPSC production is induction of pluripotency via mRNA (Warren et al, 2012;Yoshioka et al, 2013) or protein (Kim et al, 2009;Lee et al, 2012). These iPSCs are called "clean" iPSCs.…”
Abstract-Direct epigenetic reprogramming is a technique that converts a differentiated adult cell into another differentiated cell-such fibroblasts to cardiomyocytes-without passage through an undifferentiated pluripotent stage. This novel technology is opening doors in biological research and regenerative medicine. Some preliminary studies about direct reprogramming started in the 1980s when differentiated adult cells could be converted into other differentiated cells by overexpressing transcription-factor genes. These studies also showed that differentiated cells have plasticity. Direct reprogramming can be a powerful tool in biological research and regenerative medicine, especially the new frontier of personalized medicine. This review aims to summarize all direct reprogramming studies of somatic cells by master control genes as well as potential applications of these techniques in research and treatment of selected human diseases.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.